Osang Healthcare Co., Ltd. (036220) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Osang Healthcare Co., Ltd. (036220:KRX), powered by AI.

Current Price
₩6,610
P/E Ratio
30.4
Market Cap
94.6B
Sector
Healthcare
What is the Osang Healthcare Co., Ltd. stock price forecast?

Osang Healthcare Co., Ltd. is currently trading at ₩6,610. View real-time AI analysis on Alpha Lenz.

What is Osang Healthcare Co., Ltd. insider trading activity?

View the latest insider trading data for Osang Healthcare Co., Ltd. on Alpha Lenz.

What is Osang Healthcare Co., Ltd.'s P/E ratio?

Osang Healthcare Co., Ltd.'s P/E ratio is 30.4.

Osang Healthcare Co., Ltd.

KRX · 036220
₩6,610+10(+0.15%)Market closedKRX regular session 09:00–15:30 KST
Ask about Osang Healthcare Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Osang Healthcare Co., Ltd. trades at a P/E of 30.4 (premium valuation) with modest ROE of 1.1%.

Ask for details

Company Overview

Osang Healthcare Co., Ltd. is a globally recognized company specializing in the development and manufacture of in vitro diagnostic devices and medical instruments. Founded in South Korea, Osang Healthcare's primary function is to provide high-quality diagnostic solutions that contribute to advancing global health standards. The company is notably involved in producing a diverse product range including glucose monitoring systems, infectious disease test kits, and molecular diagnostic equipment. With a strong focus on innovation and research, Osang Healthcare's products cater to a variety of sectors such as hospitals, clinics, and laboratories around the world. This company plays a crucial role in the healthcare industry by enabling accurate and early detection of diseases, thereby supporting preventive healthcare measures. Through its commitment to quality and technological advancement, Osang Healthcare not only enhances patient care but also reinforces its significance within the medical diagnostics market, addressing the growing global demand for reliable and efficient testing solutions.

CEO강철훈, 유병열(각자대표이사)
SectorHealthcare
IndustryMedical Devices
Employees354

Company Statistics

FY 2025

Profile

₩94,585,239,760Market Cap
₩128,628,728,660Revenue
14.31MShares Out
354Employees

Margins

44.43%Gross
9.06%EBITDA
1.89%Operating
1.97%Pre-Tax
2.42%Net

Valuation

30.42P/E
0.34P/B
0.74EV/Sales
10.09EV/EBITDA
-7.39P/FCF

Growth (CAGR)

-12.78%Rev 3Yr
-12.99%Rev 5Yr
-63.35%Op Inc 3Yr
-56.77%Op Inc 5Yr
-57.57%Net Inc 3Yr
-52.24%Net Inc 5Yr

Returns

0.98%ROA
1.10%ROE
1.15%ROIC

Financial Health

₩21,589,877,230Cash & Cash Equivalents
₩33,296,882,240Net Debt
19.51%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Osang Healthcare Co., Ltd. (ticker: 036220) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 354 employees. Market cap is $94.6B.

The current price is ₩6,610 with a P/E ratio of 30.42x and P/B of 0.34x.

ROE is 1.10% and operating margin is 1.89%. Annual revenue is $128.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Osang Healthcare Co., Ltd. (036220) Stock Forecast 2026 ₩6,610 — Price, Financials & Analyst Targets | Alpha Lenz